Home
Public services
Dashboard
Curated content
Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
CytoCan
Save
CytoCan
Uses a modular platform called abzed to create fusion proteins with multiple functions.
Market cap
-
Enterprise valuation
CAD8—11m
(Dealroom.co estimates Feb 2023.)
Shaanxi China (HQ)
http://cytocan.com
B2B
manufacturing
commission
health
biotechnology
hard tech
biotechnology
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
CytoCan funding
CytoCan investors
Edit
Date
Investors
Amount
Round
Feb 2023
*
XtalPi
BOPU
CNY10.0m
Seed
Total Funding
CAD1.9m
Related Content
Recent News about CytoCan
Edit